Revised SPC: Mirapexin (pramipexole) tablets (all strengths and presentations)

Sections 4.2 and 4.4 now advise abrupt discontinuation of dopaminergic therapy can lead to the development of a neuroleptic malignant syndrome or a dopamine agonist withdrawal syndrome.

electronic Medicines compendium